Skip to content
Abierto
Menu

Award notice, first published as presolicitation

Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP)

75A50125R00006

Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).

View on SAM.govMarkdown

Awarded

Albert B. Sabin Vaccine Institute, Inc. (The)

$1,042,099,118.00 on the award notice, May 5, 2026, contract 75A50126C00001

Description

As published on SAM.gov.

This acquisition will allow BARDA to invest Project BioShield funds for the advanced development, US Food and Drug Administration (FDA) licensure, procurement, shipping, and vendor managed inventory (VMI) storage of MARV monovalent vaccine. This contract was awarded on a hybrid cost reiumbursement/fixed price basis as circumstances do not allow the agency to define its requirements sufficiently to allow for a fixed-price type contract.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Albert B. Sabin Vaccine Institute, Inc. (The)
UEI
H5E8NU6N2HZ5
CAGE
5MPW2
Vendor location
Washington, DC
Contract
75A50126C00001, definitive contract
Obligated
$263,613,186.00, potential $1,042,099,118
Actions
2 between May 5, 2026 and August 19, 2026
Competition
Full and Open Competition, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (Smart-Prep)
Match
award number 75A50126C00001 equals the contract number; same awarding office 75A501 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. June 27, 2025

    Presolicitation

    Marburg virus (MARV) and Sudan virus (SUDV) Vaccines

    Due July 11, 2025 at 12:00 PM EDT. SAM.gov, notice 66553ff7754346dca558f3e8719cb32b

  2. July 13, 2025

    Solicitation, originally presolicitation

    Marburg virus (MARV) and Sudan virus (SUDV) Vaccines

    Due August 26, 2025 at 2:00 PM EDT. SAM.gov, notice 1245b97261a248c098f549dc050eb35a

  3. July 14, 2025

    Solicitation

    Marburg virus (MARV) and Sudan virus (SUDV) Vaccines

    Due August 26, 2025 at 2:00 PM EDT. SAM.gov, notice fb1420f8176f4a6b89f7a21fb7569726

  4. July 31, 2025

    Solicitation

    Marburg virus (MARV) and Sudan virus (SUDV) Vaccines

    Due August 27, 2025 at 2:00 PM EDT. SAM.gov, notice fba2112d7da54dc49033b9adbe509953

  5. May 7, 2026

    Award notice

    Awarded to ALBERT B. SABIN VACCINE INSTITUTE, Inc. (THE) Washington for $1,042,099,118. SAM.gov, notice 3df48ade7cef4a8482cc8139deab5e1c

Points of contact

Also open from this buyer